New Jazz cancer drug approval could drive blockbuster sales
STAT+: Sword Health to acquire Headspace, according to filing
Roche, Eli Lilly get FDA nod for new Alzheimer’s blood test
Pennsylvania reports first 2 measles deaths in the U.S. this year, both people unvaccinated
STAT+: How Trump’s funding cuts are reshaping the health system
Young startups miss out on biotech venture funding rebound, MassBio says
The restructuring comes after an unnamed "large pharmaceutical customer" terminated a contract with the company, Cellares CEO Fabian Gerlinghaus posted on LinkedIn. Read More
WASHINGTON — In the past three years, Robert F. Kennedy Jr. has had a dramatic ascent, rocketing from the contrarian fringe to the center of the American health...
The Food and Drug Administration approved on Thursday a gene therapy for severe leukocyte adhesion deficiency type 1 (LAD-1), an ultra-rare disease that leaves children vulnerable...
WASHINGTON — A motivational coach, a venture capitalist who worked with health secretary Robert F. Kennedy Jr.’s son, and a number of health care executives whose...
Scan to Read